Company Nunzia Pharmaceutical Corporation Other OTC
Equities
NUNZ
US67097W1027
Pharmaceuticals
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Sara Gonzales
CEO | Chief Executive Officer | 51 | - |
President | 68 | 08-12-31 | |
Shujie Cui
CTO | Chief Tech/Sci/R&D Officer | 62 | 19-12-04 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
President | 68 | 08-12-31 | |
Shujie Cui
CTO | Chief Tech/Sci/R&D Officer | 62 | 19-12-04 |
Sara Gonzales
CEO | Chief Executive Officer | 51 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 51,000 | 0 | 0 | 18.04 % |
Stock B | 1 | 434,514,578 | 78,406,578 ( 18.04 %) | 0 |
Company contact information
Nunzia Pharmaceutical Corp.
1627 West 14th Street
90813, Long Beach
+714 609 9117
![address Nunzia Pharmaceutical Corporation(NUNZ)](https://cdn.zonebourse.com/static/address/5838936.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+61.53% | 848B | |
+33.93% | 627B | |
-3.66% | 363B | |
+15.06% | 318B | |
+9.18% | 299B | |
+11.25% | 234B | |
+15.38% | 225B | |
+15.67% | 179B | |
+2.47% | 167B |